TNFRSF4 and neoplasm: The relevance of OX40 to the local immune response in HNSCC has been demonstrated by the observation that close to 30% of T-cells within the tumor and tumor-draining lymph nodes of HNSCC patients expressed OX40, compared to none of the peripheral blood mononuclear cells (PBMCs) [33].